Skip to main content
Caplight Logo









Inato

Inato

Private
ParisHealthcare & Life Scienceshttps://www.inato.com/

Last Round

Series A

Extension

Mar 29, 2023

Total Funding Raised

$35.52M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Inato is a health technology company that provides an AI-powered platform to connect pharmaceutical sponsors, research sites, and patients to improve the accessibility, inclusivity, and efficiency of clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Medical AI, Patient Engagement

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS

AI Layer

Application

Keywords

clinical trial marketplaceclinical trial platformpatient recruitmentsite selectionAI for clinical trialsClinTechpatient diversitycommunity research sitessite networkpatient enrollmentdecentralized clinical trialsDCTAI patient pre-screeningcontract research organizationCROoncology trialssite activationclinical trial design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inato Comparables

Compare Inato with similar companies based on industry and business-model similarity.

Inato comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elligo Health Research
77%
OneStudyTeam
75%
Paradigm Health
74%

Inato Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 29, 2023
Series AFeb 4, 2020
SeedNov 15, 2017

Key People

Founding team and executive leadership

Kourosh Davarpanah

Cofounder & CEO

Founding Team

Bastien Duret

Chief Technology Officer

Executive Team

Inato Investors

Notable investors and investment history

Inato investors
InvestorRounds
Kima VenturesSeed
Top Harvest CapitalSeries A Extension
Top Harvest CapitalSeries A Extension
Serena Data VenturesSeries A
Obvious VenturesSeries A Extension, Series A
Fly VenturesSeries A, Seed
La Maison PartnersSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Recognized on Fierce Healthcare’s Fierce 15 list.

  • Apr 1, 2026

    Platform now used by over 5,500 sites globally.

Inato Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inato Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inato's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range74
Year Founded2016
Last FundingMar 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?